A2A adenosine receptor antagonists -: future drugs for Parkinson's disease?

被引：52

作者：

Müller, CE ^{[1
]}

机构：

[1] Univ Bonn, Inst Pharmaceut, D-53115 Bonn, Germany

来源：

DRUGS OF THE FUTURE | 2000年 / 25卷 / 10期

关键词：

D O I：

10.1358/dof.2000.025.10.858696

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1043 / 1052

页数：10

共 106 条

[81]

Peterfreund RA, 1996, J NEUROCHEM, V66, P362

[82] Effects of SCH 58261, an adenosine A2A receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats:: Lack of tolerance after chronic caffeine intake [J].

Popoli, P ;

Reggio, R ;

Pèzzola, A .

NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) :522-529

[83] Pharmacodynamics of ZM 241385, a potent A(2a) adenosine receptor antagonist, after enteric administration in rat, cat and dog [J].

Poucher, SM ;

Keddie, JR ;

Brooks, R ;

Shaw, GR ;

McKillop, D .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (06) :601-606

[84] THE IN-VITRO PHARMACOLOGY OF ZM-241385, A POTENT, NONXANTHINE, A(2A) SELECTIVE ADENOSINE RECEPTOR ANTAGONIST [J].

POUCHER, SM ;

KEDDIE, JR ;

SINGH, P ;

STOGGALL, SM ;

CAULKETT, PWR ;

JONES, G ;

COLLIS, MG .

BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1096-1102

[85] Adenosine receptors: New opportunities for future drugs [J].

Poulsen, SA ;

Quinn, RJ .

BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (06) :619-641

[86]

Ralevic V, 1998, PHARMACOL REV, V50, P413

[87]

Richardson P J, 1999, Adv Neurol, V80, P111

[88] Adenosine A(2A) receptor antagonists as new agents for the treatment of Parkinson's disease [J].

Richardson, PJ ;

Kase, H ;

Jenner, PG .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (09) :338-344

[89] Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells [J].

Salim, H ;

Ferré, S ;

Dalal, A ;

Peterfreund, RA ;

Fuxe, K ;

Vincent, JD ;

Lledo, PM .

JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :432-439

[90] Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists [J].

Sauer, R ;

Maurinsh, J ;

Reith, U ;

Fülle, F ;

Klotz, KN ;

Müller, CE .

JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (03) :440-448

← 2 3 4 5 6 7 8 9 10 11 →